Marinus Pharmaceuticals, Inc. (MRNS) |
| 0.55 0 (0%) 02-10 16:00 |
| Open: | 0.5492 |
| High: | 0.55 |
| Low: | 0.5492 |
| Volume: | 1,100,953 |
| Market Cap: | 30(M) |
| PE Ratio: | -0.22 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 37.74 |
| Resistance 1: | 35.13 |
| Pivot price: | 34.38 |
| Support 1: | 30.92 |
| Support 2: | 25.73 |
| 52w High: | 10.5 |
| 52w Low: | 0.22 |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Sun, 30 Aug 2026
Marinus Pharmaceuticals Inc. (MRNS) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Wed, 05 Aug 2026
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Marinus - TMX Newsfile
Mon, 06 Jan 2025
Immedica acquires Marinus in $151 million deal - The Pharma Letter
Mon, 30 Dec 2024
Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc. - Business Wire
Tue, 12 Nov 2024
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results - Business Wire
Tue, 10 Sep 2024
Marinus Pharmaceuticals to Present at the 2024 Cantor Global Healthcare Conference - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
